Opinion - Immunotherapy and chemotherapy - a practical partnership
被引:532
作者:
Lake, RA
论文数: 0引用数: 0
h-index: 0
机构:
Western Australian Inst Med Res, Sch Med & Pharmacol, Tumour Immunol Grp, Perth, WA 6009, AustraliaWestern Australian Inst Med Res, Sch Med & Pharmacol, Tumour Immunol Grp, Perth, WA 6009, Australia
Lake, RA
[1
]
Robinson, BWS
论文数: 0引用数: 0
h-index: 0
机构:Western Australian Inst Med Res, Sch Med & Pharmacol, Tumour Immunol Grp, Perth, WA 6009, Australia
Robinson, BWS
机构:
[1] Western Australian Inst Med Res, Sch Med & Pharmacol, Tumour Immunol Grp, Perth, WA 6009, Australia
[2] Sir Charles Gairdner Hosp, Sch Med & Pharmacol, Perth, WA 6009, Australia
This article discusses how recent data have altered the way we understand how dying tumour cells, particularly those killed by chemotherapy, engage with antitumour immune responses. These data have significant implications for the development of new protocols combining chemotherapy with immunotherapy, indicating an exciting potential for therapeutic synergy with general applicability to many cancer types.